
Product Specifications
MYGLIPT is a DPP-4 inhibitor that increases serum adiponectin level. It reduces insulin resistance, improves endothelial function and left ventricular function. This medicine increases beta-cell function and improves insulin resistance and serum lipid profile.
It is also available in:
MYGLIPT-M TAB
Company Information
Ask for more detail from the seller
Contact Supplier